期刊
MOLECULAR AND CLINICAL ONCOLOGY
卷 5, 期 1, 页码 132-134出版社
SPANDIDOS PUBL LTD
DOI: 10.3892/mco.2016.898
关键词
prostate; sarcoma; leiomyosarcoma; immunohistochemistry; prognosis
类别
资金
- Key Project of Science and Technology of Zigong [2015SF03]
- Scientific research project of Health Department of Sichuan Province [110590]
Prostate sarcoma, particularly the pathological type of leiomyosarcoma, is a rare carcinoma, which originated from the interstitial tissue of the prostate. This sarcoma type has a poor prognosis. This disease accounts for similar to 0.1% of all prostate cancer and it usually occurrs in patients aged between 40 and 78-years-old. Although prostate leiomyosarcoma has a poor prognosis, early treatment of post-operative recurrence and metastases via a whole-body examination and closer follow-up was possible. These measurements may significantly prolong the survival time and improve the quality of life. The present study reported a successful case of surgical management for prostate leiomyosarcoma in the Zigong No. 4 People's Hospital (Sichuan, China) during 1995 until 2015, with post-operative follow-up for 20 years.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据